glp 1 mood swings Excellent article by Anuja Jaiswal in The Times of India on the behavioural and psychological impact of GLP-1 medications, and why changes during weight-loss therapy need careful monitoring. Thank you for GLP-1 medication and mental health:

Drug labeling for semaglutide products also reflects this concern and advises monitoring patients with a history of diabetic retinopathy

While it is true that the United States has the largest GLP-1 market in the world, data from the last few years shows that GLP-1s have become popular in other markets such as the United Kingdom, who is currently leading the European market with their rise in NHS Ozempic Prescriptions

The lesion extends across the residual alveolar ridge onto the palate and onto the facial aspect of the ridge

December 2025: JPML creates MDL for the Ozempic NAION vision loss claims

2 were cohort studies, and 4 were case series studies